Current information on the immunologic status of occult hepatitis B infection

被引:55
作者
Arababadi, Mohammad Kazemi [1 ]
Ahmadabadi, Behzad Nasiri
Kennedy, Derek
机构
[1] Rafsanjan Univ Med Sci, Sch Med, Dept Microbiol & Immunol, Mol Med Res Ctr, Rafsanjan 7719617996, Iran
关键词
VITAMIN-D-RECEPTOR; VIRUS-INFECTION; IRANIAN PATIENTS; PROMOTER POLYMORPHISM; GENE POLYMORPHISMS; IMMUNE-RESPONSES; CCR5; EXPRESSION; HBV INFECTION; SERUM-LEVEL; C VIRUS;
D O I
10.1111/j.1537-2995.2012.03575.x
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Hepatitis B is one of the most frequently occurring posttransfusion infections. Occult hepatitis B (OB) is a form of hepatitis B in which, despite the presence of hepatitis B virus (HBV) DNA in the serum and hepatocytes of a carrier, hepatitis B surface antigen is absent. In addition to the risk of transfusion of infection, OB can lead to cirrhosis, hepatic cancer, and reactivation of the viral duplication process in the carrier. The mechanisms responsible for progression of OB are yet to be clarified; however, some investigators have suggested that genetic and immunologic variables may play a significant role in the resistance of some individuals and sensitivity of other patients. This review addresses the current information regarding immunologic status of OB-infected patients.
引用
收藏
页码:1819 / 1826
页数:8
相关论文
共 52 条
[1]
Impact of the-308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease [J].
Abraham, LJ ;
Kroeger, KM .
JOURNAL OF LEUKOCYTE BIOLOGY, 1999, 66 (04) :562-566
[2]
Occult Hepatitis B Virus Infection in Hemodialysis Patients With Isolated Hepatitis B Core Antibody: A Multicenter Study [J].
Aghakhani, Arezoo ;
Banifazl, Mohammad ;
Kalantar, Ebrahim ;
Eslamifar, Ali ;
Ahmadi, Farrokhlagha ;
Razeghi, Effat ;
Atabak, Shahnaz ;
Amini, Manouchehr ;
Khadem-Sadegh, Akbar ;
Ramezani, Amitis .
THERAPEUTIC APHERESIS AND DIALYSIS, 2010, 14 (03) :349-353
[3]
Clinical and Laboratory Findings in Hyper-IgM Syndrome with Novel CD40L and AICDA Mutations [J].
Aghamohammadi, Asghar ;
Parvaneh, Nima ;
Rezaei, Nima ;
Moazzami, Kasra ;
Kashef, Sara ;
Abolhassani, Hassan ;
Imanzadeh, Amir ;
Mohammadi, Javad ;
Hammarstrom, Lennart .
JOURNAL OF CLINICAL IMMUNOLOGY, 2009, 29 (06) :769-776
[4]
CCR5 in T cell-mediated liver diseases: What's going on? [J].
Ajuebor, Maureen N. ;
Carey, Jillian A. ;
Swain, Mark G. .
JOURNAL OF IMMUNOLOGY, 2006, 177 (04) :2039-2045
[5]
Long-term protection of hepatitis B vaccine 18 years after vaccination [J].
AlFaleh, Faleh ;
AlShehri, Suliman ;
AlAnsari, Saleh ;
AlJeffri, Mohammed ;
AlMazrou, Yaqoub ;
Shaffi, Ahmad ;
Abdo, Ayman A. .
JOURNAL OF INFECTION, 2008, 57 (05) :404-409
[6]
Arababadi MK, 2009, J GUIL U MED SCI, V18, P1
[7]
Non-association of IL-12+1188 and IFN-γ+874 polymorphisms with cytokines serum level in occult HBV infected patients [J].
Arababadi, Mohammad K. ;
Pourfathollah, Ali A. ;
Jafarzadeh, Abdollah ;
Hassanshahi, Gholamhossein ;
Daneshmandi, Saeed ;
Shamsizadeh, Ali ;
Kennedy, Derek .
SAUDI JOURNAL OF GASTROENTEROLOGY, 2011, 17 (01) :30-35
[8]
Arababadi MK, 2011, HEPAT MON, V11, P714, DOI [10.5812/kowsar.1735143X.694, 10.5812/kowsar.1735143X.505]
[9]
Arababadi MK, 2011, HEPAT MON, V11, P23
[10]
The status of humoral immunity in occult HBV infection in south-eastern Iranian patients [J].
Arababadi, Mohammad Kazemi ;
Pourfathollah, Ali Akbar ;
Jafarzadeh, Abdollah ;
Hassanshahi, Gholamhossein ;
Shamizadeh, Ali ;
Ahmadabadi, Behzad Nasiri ;
Kennedy, Derek .
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2011, 35 (04) :309-314